Among miRNAs potentially involved in the cross-talk between EGFR-stimulated MSCs and breast cancer cells, we identified miR-23c and suggested a role of this miRNA as a tumor suppressor in MDA-MB-468 and MDA-MB-231 breast cancer cells, through the inhibition of IL-6R. Here, IL6R is linked to neoplasm.